Literature DB >> 17082351

Endogenous cholecystokinin reduces food intake and increases Fos-like immunoreactivity in the dorsal vagal complex but not in the myenteric plexus by CCK1 receptor in the adult rat.

Cherese N Sullivan1, Shannon J Raboin, Stephen Gulley, Ntwenzi T Sinzobahamvya, Gary M Green, Joseph R Reeve, Ayman I Sayegh.   

Abstract

We hypothesized that endogenous CCK reduces food intake by activating the dorsal vagal complex (DVC) and the myenteric neurons of the gut. To test this hypothesis, adult rats were given camostat mesilate; a nonnutrient releaser of endogenous CCK, by orogastric gavage, and Fos-like immunoreactivity (Fos-LI) was quantified in the DVC and the myenteric plexus. The results for endogenous CCK were compared with those for exogenous CCK-8. Exogenous CCK-8 reduced food intake and stimulated Fos-LI in the DVC and in myenteric neurons of the duodenum and jejunum. In comparison, endogenous CCK reduced food intake and increased DVC Fos-LI but did not increase Fos-LI in the myenteric plexus. Similar to CCK-8, devazepide, a specific CCK(1) receptor antagonist, and not L365,260, a specific CCK(2) receptor antagonist, attenuated the reduction of food intake by camostat. In addition, Fos-LI in the DVC in response to both exogenous CCK-8 and camostat administration was significantly attenuated by vagotomy, as well as by blocking CCK(1) receptors. These results demonstrate for the first time that reduction of food intake in adult rats by endogenous CCK released by a nonnutrient mechanism requires CCK(1) receptors, the vagus nerve, and activation of the DVC, but not the myenteric plexus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17082351     DOI: 10.1152/ajpregu.00490.2006

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  15 in total

1.  Non-sulfated cholecystokinin-8 increases enteric and hindbrain Fos-like immunoreactivity in male Sprague Dawley rats.

Authors:  Amged I Dafalla; Thaer R Mhalhal; Kenneth Hiscocks; John Heath; Ayman I Sayegh
Journal:  Brain Res       Date:  2018-12-17       Impact factor: 3.252

2.  Control of lipid metabolism by tachykinin in Drosophila.

Authors:  Wei Song; Jan A Veenstra; Norbert Perrimon
Journal:  Cell Rep       Date:  2014-09-25       Impact factor: 9.423

Review 3.  The role of gastrointestinal vagal afferent fibres in obesity.

Authors:  Stephen J Kentish; Amanda J Page
Journal:  J Physiol       Date:  2014-12-23       Impact factor: 5.182

4.  Intestinal serine protease inhibition increases FGF21 and improves metabolism in obese mice.

Authors:  Kamal Albarazanji; Matthew Jennis; Cassandre R Cavanaugh; Wensheng Lang; Bhanu Singh; James C Lanter; James M Lenhard; Pamela J Hornby
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-03-28       Impact factor: 4.052

Review 5.  Peripheral neural targets in obesity.

Authors:  Amanda J Page; Erin Symonds; Madusha Peiris; L Ashley Blackshaw; Richard L Young
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

6.  Long-term effect of parasympathetic or sympathetic denervation on intestinal epithelial cell proliferation and apoptosis.

Authors:  Elizabeth A Davis; Martha C Washington; Emily R Yaniz; Heidi Phillips; Ayman I Sayegh; Megan J Dailey
Journal:  Exp Biol Med (Maywood)       Date:  2017-08-02

7.  CCK-8 and CCK-58 differ in their effects on nocturnal solid meal pattern in undisturbed rats.

Authors:  Miriam Goebel-Stengel; Andreas Stengel; Lixin Wang; Gordon Ohning; Yvette Taché; Joseph R Reeve
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-08-08       Impact factor: 3.619

8.  Roux-en-Y gastric bypass reverses the effects of diet-induced obesity to inhibit the responsiveness of central vagal motoneurones.

Authors:  Kirsteen N Browning; Samuel R Fortna; Andras Hajnal
Journal:  J Physiol       Date:  2013-03-04       Impact factor: 5.182

9.  Peptide YY3-36 and 5-hydroxytryptamine mediate emesis induction by trichothecene deoxynivalenol (vomitoxin).

Authors:  Wenda Wu; Melissa A Bates; Steven J Bursian; Brenna Flannery; Hui-Ren Zhou; Jane E Link; Haibin Zhang; James J Pestka
Journal:  Toxicol Sci       Date:  2013-03-01       Impact factor: 4.849

10.  Effects of cholecystokinin-58 on type 1 cholecystokinin receptor function and regulation.

Authors:  S Vincent Wu; Kaleeckal G Harikumar; Rebecca J Burgess; Joseph R Reeve; Laurence J Miller
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-09       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.